Infection Viral
Conditions
Keywords
COVID-19, SARS-CoV-2, coronavirus, biological samples
Brief summary
The coronavirus disease 2019 (COVID-19) outbreak is now considered as a public health emergency of international concern by the World Health Organization. In the context of the health emergency, research on the pathogen (the SARS-CoV-2 coronavirus), the disease and the therapeutic care is being organized. Research projects require the use of biological samples. This study aims at setting up a collection of biological samples intended for application projects in any discipline. The main objective of the study is to collect, process and store biological samples from patients and caregivers infected with SARS-CoV-2 (COVID-19) at the biological ressources center of the Bordeaux University Hospital.
Interventions
collection of whole blood samples, urine and stool samples, upper respiratory samples, post-mortem biopsies
Sponsors
University Hospital, Bordeaux
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No
Inclusion criteria
* Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2 * men and women, adults and minors as well as pregnant or breastfeeding women * patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies) * Be affiliated with or beneficiary of a social security scheme * Free and informed consent obtained and signed by the patient
Exclusion criteria
* Under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COVID-19 desease description | Inclusion visit (Day 1) | From blood samples: protein levels, whole genome sequence, transcriptomic analysis data. From upper respiratory samples: protein levels, virus transcriptomic analysis data. From stool: microbiota analysis data. From urine: protein level. |
Countries
France
Outcome results
None listed